LI
TEVA icon

Leap Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Leap Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$316K Buy
+25,600
New +$290K 0.21% 192
2020
Q1 		– Sell
-181,376
Closed -$1.78M – 558
2019
Q4 		$1.78M Buy
+181,376
New +$1.62M 0.83% 11

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Leap Investments's TEVA Position: Q2 2020 in Review

Leap Investments opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2020: 25,600 shares worth $316K. The stake represents 0.21% of the portfolio and ranks #192 among its holdings. This is a return to the name: Leap Investments previously reported a position in TEVA as recently as Q4 2019.

Leap Investments first reported a position in TEVA in Q4 2019 and has held it in 2 quarters since. The position peaked at $1.78M in Q4 2019. 455 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • Leap Investments held 25,600 shares of Teva Pharmaceuticals worth $316K as of Q2 2020.
  • Teva Pharmaceuticals was a new Leap Investments position in Q2 2020.
  • Teva Pharmaceuticals made up 0.21% of Leap Investments's portfolio in Q2 2020, its #192 holding.
  • Leap Investments first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 2 quarters since.
  • Leap Investments's Teva Pharmaceuticals position peaked at $1.78M in Q4 2019.
  • 455 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.